FDA Takes Actions to Expand Use of Treatment for Outpatients with Mild-to-Moderate COVID-19
2022-01-22
The U.S. Food and Drug Administration took two actions this week to expand the use of the antiviral drug Veklury (remdesivir) to certain non-hospitalized adults and pediatric patients for the treatment of mild-to-moderate COVID-19 disease. This provides another treatment option to reduce the risk of hospitalization in high-risk patients. Previously,Continue Reading
